Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,057 public trials 2,038 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer

NCT00019656

Conditions: Bone Marrow Diseases, Burkitt Lymphoma, Chronic Disease, +39 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details

Completed

UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia

NCT00019838

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details

Completed

Flavopiridol in Treating Patients With Refractory Cancer

NCT00019344

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +52 more
Locations: Medicine Branch Bethesda, Maryland, United States

View Trial Details

Completed

Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia

NCT00021983

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma

NCT00020111

Conditions: Bone Marrow Diseases, Burkitt Lymphoma, Chronic Disease, +30 more
Locations: Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States

Children's Hospital Los Angeles Los Angeles, California, United States

View all 52 locations

View Trial Details

Completed

Analysis of Genes Present in Cutaneous T-cell Lymphoma Cells

NCT00020072

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Depsipeptide in Treating Patients With Solid Tumors

NCT00019318

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Medicine Branch Bethesda, Maryland, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia

NCT00019032

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT

NCT00506922

Conditions: Graft vs Host Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia

NCT00217646

Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia, +52 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions